Patents by Inventor Chuenlei Parng

Chuenlei Parng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240076386
    Abstract: The invention provides antibodies, and antigen-binding fragments thereof, that specifically bind to E-selectin. The invention includes uses, and associated methods of using the antibodies, and antigen-binding fragments thereof.
    Type: Application
    Filed: February 27, 2023
    Publication date: March 7, 2024
    Inventors: James Reasoner Apgar, Sheryl Rubio Bowley, Joanne Elizabeth-Ayriss Elwell, Laura Lin, Jatin Narula, Chuenlei Parng, Debra Denene Pittman, Swapnil Rakhe, Chihyi Vincent Yu
  • Patent number: 11597770
    Abstract: The invention provides antibodies, and antigen-binding fragments thereof, that specifically bind to E-selectin. The invention includes uses, and associated methods of using the antibodies, and antigen-binding fragments thereof.
    Type: Grant
    Filed: January 21, 2021
    Date of Patent: March 7, 2023
    Assignee: Pfizer Inc.
    Inventors: James Reasoner Apgar, Sheryl Rubio Bowley, Joanne Elizabeth-Ayriss Elwell, Laura Lin, Jatin Narula, Chuenlei Parng, Debra Denene Pittman, Swapnil Rakhe, Chihyi Vincent Yu
  • Publication number: 20210246213
    Abstract: The invention provides antibodies, and antigen-binding fragments thereof, that specifically bind to E-selectin. The invention includes uses, and associated methods of using the antibodies, and antigen-binding fragments thereof.
    Type: Application
    Filed: January 21, 2021
    Publication date: August 12, 2021
    Inventors: James Reasoner Apgar, Sheryl Rubio Bowley, Joanne Elizabeth-Ayriss Elwell, Laura Lin, Jatin Narula, Chuenlei Parng, Debra Denene Pittman, Swapnil Rakhe, Chihyi Vincent Yu
  • Patent number: 8993834
    Abstract: The present invention provides methods of screening an agent for activity using teleosts. Methods of screening an agent for angiogenesis activity, toxic activity and an effect cell death activity in teleosts are provided. Methods of screening an agent for an activity in the brain or central nervous system in zebrafish are provided. The invention further provides high throughput methods of screening agents in multi-well plates.
    Type: Grant
    Filed: May 6, 2013
    Date of Patent: March 31, 2015
    Assignee: Phylonix Pharmaceuticals, Inc.
    Inventors: Patricia McGrath, Chuenlei Parng, George N. Serbedzija
  • Publication number: 20120317663
    Abstract: The present invention provides methods of screening an agent for activity using teleosts. Methods of screening an agent for angiogenesis activity, toxic activity and an effect cell death activity in teleosts are provided. Methods of screening an agent for an activity in the brain or central nervous system in zebrafish are provided. The invention further provides high throughput methods of screening agents in multi-well plates.
    Type: Application
    Filed: March 7, 2012
    Publication date: December 13, 2012
    Applicant: Phylonix Pharmaceuticals, Inc.
    Inventors: Patricia McGrath, Chuenlei Parng, George N. Serbedzija
  • Publication number: 20110219463
    Abstract: The present invention provides methods of screening an agent for activity using teleosts. Methods of screening an agent for angiogenesis activity, toxic activity and an effect cell death activity in teleosts are provided. Methods of screening an agent for an activity in the brain or central nervous system in zebrafish are provided. The invention further provides high throughput methods of screening agents in multi-well plates.
    Type: Application
    Filed: May 11, 2011
    Publication date: September 8, 2011
    Inventors: Patricia McGrath, Chuenlei Parng, George N. Serbedzija
  • Patent number: 7951989
    Abstract: The present invention provides methods of screening an agent for activity using teleosts. Methods of screening an agent for angiogenesis activity, toxic activity and an effect cell death activity in teleosts are provided. Methods of screening an agent for an activity in the brain or central nervous system in zebrafish are provided. The invention further provides high throughput methods of screening agents in multi-well plates.
    Type: Grant
    Filed: September 1, 2006
    Date of Patent: May 31, 2011
    Assignee: Phylonix Pharmaceuticals, Inc.
    Inventors: Patricia McGrath, Chuenlei Parng, George N. Serbedzija
  • Patent number: 7767880
    Abstract: The present invention provides methods of screening an agent for activity using teleosts. Methods of screening an agent for angiogenesis activity, toxic activity and an effect cell death activity in teleosts are provided. Methods of screening an agent for an activity in the brain or central nervous system in zebrafish are provided. The invention further provides high throughput methods of screening agents in multi-well plates.
    Type: Grant
    Filed: October 29, 2007
    Date of Patent: August 3, 2010
    Assignee: Phylonix Pharmaceuticals, Inc.
    Inventors: Patricia McGrath, Chuenlei Parng, George N. Serbedzija
  • Publication number: 20080152591
    Abstract: The present invention provides methods of screening an agent for activity using teleosts. Methods of screening an agent for angiogenesis activity, toxic activity and an effect cell death activity in teleosts are provided. Methods of screening an agent for an activity in the brain or central nervous system in zebrafish are provided. The invention further provides high throughput methods of screening agents in multi-well plates.
    Type: Application
    Filed: October 29, 2007
    Publication date: June 26, 2008
    Applicant: Phylonix Pharmaceuticals, Inc.
    Inventors: Patricia McGrath, Chuenlei Parng, George N. Serbedzija
  • Publication number: 20070143865
    Abstract: The present invention provides methods of screening an agent for activity using teleosts. Methods of screening an agent for angiogenesis activity, toxic activity and an effect cell death activity in teleosts are provided. Methods of screening an agent for an activity in the brain or central nervous system in zebrafish are provided. The invention further provides high throughput methods of screening agents in multi-well plates.
    Type: Application
    Filed: September 1, 2006
    Publication date: June 21, 2007
    Applicant: Phylonix Pharmaceuticals, Inc.
    Inventors: Patricia McGrath, Chuenlei Parng, George Serbedzija